Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Centuri, Medpace, and Franklin and Encourages Investors to Contact the Firm
October 08, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against MaxLinear, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, Centuri, Liquidia, and Elastic and Encourages Investors to Contact the Firm
September 16, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Paragon 28, Inc. (NYSE:...
Bragar Eagel & Squire, P.C. Is Investigating Centuri, Medpace, Customers Bancorp, and Globus and Encourages Investors to Contact the Firm
August 30, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Centuri Holdings, Inc...
Bragar Eagel & Squire, P.C. Is Investigating Centuri, Target Hospitality, Helios, and LegalZoom and Encourages Investors to Contact the Firm
August 12, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Centuri Holdings, Inc...
CENTURI ALERT: Bragar Eagel & Squire, P.C. is Investigating Centuri Holdings, Inc. on Behalf of Centuri Stockholders and Encourages Investors to Contact the Firm
August 01, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Centuri Holdings, Inc....
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centuri Holdings
July 31, 2024 17:30 ET
|
Faruqi & Faruqi LLP
If you suffered significant losses in Centuri stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext....
Johnson Fistel Begins Investigation into Centuri Following a Significant Drop in the Company’s Stock Price
July 30, 2024 12:31 ET
|
Johnson Fistel, LLP
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Centuri Holdings, Inc. (NYSE: CTRI), any of its...
MATEON ANNOUNCES FIRST PATIENT ENROLLED IN ARTI-19: A MULTICENTER INTERVENTIONAL STUDY OF ARTISHIELD™ AGAINST COVID-19
October 07, 2020 07:00 ET
|
Mateon Therapeutics, Inc.
TOP-LINE DATA ANTICIPATED IN FOURTH QUARTER 2020 AGOURA HILLS, California, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β...